Melane Sampson, Author at BioTuesdays

Executive Moves

FibroBiologics names Jason D. Davis as CFO

FibroBiologics (NASDAQ: FBLG) announced the appointment of Jason D. Davis, CPA, as chief financial officer (CFO), effective immediately. Bringing extensive experience in corporate finance, capital markets, and SEC...

June 9, 2025

Developments

Aytu signs agreement to commercialize Exxua for MDD

Aytu BioPharma (ASDAQ: AYTU) announced that it has signed an exclusive agreement with closely held Fabre-Kramer Pharmaceuticals to commercialize Exxua—extended-release antidepressant tablets—in the U.S. market for major...

June 9, 2025

Developments

Vaccines publishes key benefits of PharmaJet Tropis ID vaccine over IM SoC

Closely held PharmaJet announced that the results of an implementation research study—titled Evaluating the impact of needle-free delivery of inactivated polio vaccine on Nigeria’s routine immunization program: An...

June 5, 2025

Developments

Perimeter launches OCT-Tissue Registry to power AI and imaging innovation

Perimeter Medical Imaging AI (TSXV: PINK; OTCQX: PYNKF) has announced the launch of its optical coherence tomography (OCT)-Tissue Surveillance Registry—a database designed to collect thousands of images from surgical...

June 4, 2025

Developments

Leonard Wheeler, former NFL player, named global ambassador for Profound’s TULSA-PRO

Profound Medical (NASDAQ: PROF; TSX: PRN) today announced that it has entered into a consulting agreement with Leonard Wheeler—former NFL player, entrepreneur, author, corporate consultant, co-executive director of the...

June 4, 2025

Feature

JVP Labs redefining congestive heart failure monitoring

Closely held JVP Labs is developing the only non-invasive, real-time cardiac filling pressure monitoring solution for managing congestive heart failure (CHF) patients—for both in the hospital and at home.

June 3, 2025

Executive Moves

Dyadic announces leadership change as part of strategic shift

Dyadic International (NASDAQ: DYAI) announced that its board of directors has appointed Joe Hazelton as president, effective immediately, as part of an ongoing strategic shift to evolve into a revenue-generating...

June 2, 2025

Developments

Defence opens first U.S. laboratory

Defence Therapeutics (CSE: DTC; OTCQB: DTCFF; FSE: DTC) announced that it has opened its first U.S.-based laboratory in the Boston-Cambridge area. According to Defence, the new laboratory will allow the company to...

June 2, 2025

Developments

atai and Beckley to combine establishing market leader in psychedelic mental health therapies

atai Life Sciences (NASDAQ: ATAI) and closely held Beckley Psytech announced a definitive agreement to combine in an all-share transaction subject to Phase 2b success criteria of BPl-003 in patients with treatment...

June 2, 2025

Developments

Genflow and CER agree to long-term R&D collaboration

Genflow Biosciences (LSE:GENF; OTCQB:GENFF) has announced the signing of a master service agreement (MSA) with closely held CER Groupe—a long-standing partner—to strengthen long-term research and development (R&D)...

May 28, 2025

Author - Melane Sampson

FibroBiologics names Jason D. Davis as CFO

Aytu signs agreement to commercialize Exxua for MDD

Vaccines publishes key benefits of PharmaJet Tropis ID vaccine over IM SoC

Perimeter launches OCT-Tissue Registry to power AI and imaging innovation

Leonard Wheeler, former NFL player, named global ambassador for Profound’s TULSA-PRO

JVP Labs redefining congestive heart failure monitoring

Dyadic announces leadership change as part of strategic shift

Defence opens first U.S. laboratory

atai and Beckley to combine establishing market leader in psychedelic mental health therapies

Genflow and CER agree to long-term R&D collaboration

Subscribe